ligands acting on targets

(E/Z)-GSK-3β inhibitor 1 is a racemic compound of (E)-GSK-3β inhibitor 1 and (Z)-GSK-3β inhibitor 1 isomers. GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC

(E/Z)-GSK-3β inhibitor 1 is a racemic compound of (E)-GSK-3β inhibitor 1 and (Z)-GSK-3β inhibitor 1 isomers. GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC

(E/Z)-GSK-3β inhibitor 1 is a racemic compound of (E)-GSK-3β inhibitor 1 and (Z)-GSK-3β inhibitor 1 isomers. GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC

(E/Z)-GSK5182 is a racemic compound of (E)-GSK5182 and (Z)-GSK5182 isomers. GSK5182 is a highly selective and orally active inverse agonist of estrogen-related receptor γ (ERRγ) with an IC 50 of 79 nM. GSK5182 also induces reactive oxyen species

(E/Z)-HA155.

(E/Z)-HA155.

(E/Z)-HA155.

(E/Z)-HA155.

(E/Z)-HA155.

(E/Z)-HA155.

Information(E/Z)-IT-603 is a mixture of E-IT-603 and Z-IT-603. IT-603 is a NF-κB family memberc-Relinhibitor with an IC50 of 3 μM in electrophoretic mobility shift assay (EMSA).IT-603 is a c-Rel inhibitor with an IC50 of 3 μM. IT-603 has anti-tumor

Information(E/Z)-IT-603 is a mixture of E-IT-603 and Z-IT-603. IT-603 is a NF-κB family memberc-Relinhibitor with an IC50 of 3 μM in electrophoretic mobility shift assay (EMSA).IT-603 is a c-Rel inhibitor with an IC50 of 3 μM. IT-603 has anti-tumor